| Literature DB >> 24669759 |
Andrew Koesters, Kathrin L Engisch, Mark M Rich.
Abstract
INTRODUCTION: Multisystem organ failure remains a poorly understood complication of sepsis. During sepsis, reduced excitability contributes to organ failure of skeletal muscle, nerves and the spinal cord. The goal of this study was to determine whether reduced excitability might also contribute to cardiac failure during sepsis.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24669759 PMCID: PMC4057164 DOI: 10.1186/cc13800
Source DB: PubMed Journal: Crit Care ISSN: 1364-8535 Impact factor: 9.097
Figure 1Changes in action potentials suggest reduced Na current underlies reduced excitability. (a) Three representative papillary muscle axon action potentials from healthy and septic rats are shown to demonstrate the range of amplitudes in each group. While the largest action potentials from papillary muscle in septic rats were normal in amplitude, only 35% of action potentials overshot 0 mV; whereas in healthy papillary muscles, 73% overshot 0 mV. In most traces, the stimulus artifact can be appreciated prior to the onset of the action potential. The horizontal line represents 0 mV. (b) Superimposed on an expanded timescale are two action potentials from healthy rats (solid lines) and two action potentials from septic rats (dashed lines). The action potentials from septic rats have reduced amplitudes and rate of rise, but are similar in duration to those from healthy rats. (c) Scatter plots of animal means of action potential characteristics for eleven healthy and eight septic rats. Horizontal lines represent the mean for each group. *P <0.05. AP, action potential; dV/dt, action potential rate of rise.
Characteristics of action potentials
| Healthy | −79.9 ± 1.0 | 85.5 ± 1.8 | −72.0 ± 0.5 | 59.6 ± 2.4 | 32.7 ± 2.5 | 11 (84) |
| Septic | −78.3 ± 0.6 | 66.6 ± 5.6* | −65.0 ± 1.8* | 34.0 ± 5.7* | 29.1 ± 3.2 | 8 (108) |
| TTX Studies | | | | | | |
| Pre-TTX | −77.5 ± 1.3 | 88.5 ± 4.2 | −67.9 ± 2.5 | 57.1 ± 5.1 | 35.3 ± 3.9 | 3 (14) |
| Post-TTX | −79.0 ± 2.4 | 69.1 ± 7.2 | −54.6 ± 4.0* | 22.1 ± 8.1* | 35.0 ± 0.5 | 3 (21) |
| Nifedipine studies | | | | | | |
| Pre-nifedipine | −82.5 ± 2.3 | 89.2 ± 2.6 | −70.5 ± 4.6 | 64.5 ± 5.0 | 38.5 ± 5.2 | 3 (15) |
| Post-nifedipine | −85.2 ± 0.6 | 87.3 ± 2.0 | −70.5 ± 2.7 | 52.4 ± 2.8* | 34.3 ± 3.8 | 3 (22) |
Vrest, resting potential; APA, action potential amplitude; AP threshold, action potential threshold; dV/dt, action potential rate of rise; APD 50, action potential duration at 50% of the maximal amplitude. In healthy and septic studies *P <0.05 septic vs. healthy (unpaired t test). In TTX and nifedipine studies *P <0.05 pretreatment vs. posttreatment (paired t test).
Figure 2Block of sodium channels triggers significant reduction in contractility. (a) Shown are force traces from a papillary muscle paced at 1 Hz before and after application of tetrodotoxin (TTX) and nifedipine. After each drug is washed out, contractility returns to baseline. (b) Shown is a bar graph showing the mean force at baseline, following TTX, washout of TTX (post TTX), following nifedipine, and washout of nifedipine (post Nifed) (n = 3 rats). **P <0.01.